Enhancement of alcohol aversion by the nicotinic acetylcholine receptor drug sazetidine‐A

The prevalence of alcohol use disorders (AUDs) has steadily increased in the United States over the last 30 years. Alcohol acts on multiple receptor systems including the nicotinic acetylcholine receptors (nAChRs), which are known to mediate alcohol consumption and reward. We previously reported tha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Addiction biology 2021-03, Vol.26 (2), p.e12908-n/a
Hauptverfasser: Touchette, Jillienne C., Moen, Janna K., Robinson, Jenna M., Lee, Anna M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 2
container_start_page e12908
container_title Addiction biology
container_volume 26
creator Touchette, Jillienne C.
Moen, Janna K.
Robinson, Jenna M.
Lee, Anna M.
description The prevalence of alcohol use disorders (AUDs) has steadily increased in the United States over the last 30 years. Alcohol acts on multiple receptor systems including the nicotinic acetylcholine receptors (nAChRs), which are known to mediate alcohol consumption and reward. We previously reported that the preclinical drug sazetidine‐A, a nAChR agonist and desensitizer, reduces alcohol consumption without affecting nicotine consumption in C57BL/6J mice. Here, we found that sazetidine‐A enhances the expression of alcohol aversion without affecting the expression or acquisition of conditioned alcohol reward in C57BL/6J mice. Microinjection of sazetidine‐A into the ventral midbrain targeting the ventral tegmental area (VTA) reduced binge alcohol consumption, implicating this region in mediating the effects of sazetidine‐A. Furthermore, the sazetidine‐A‐induced reduction in alcohol consumption was mediated by non‐α4 containing nAChRs, as sazetidine‐A reduced binge alcohol consumption in both α4 knock‐out and wild‐type mice. Finally, we found that in mice pretreated with sazetidine‐A, alcohol induced Fos transcript in Th‐, but not Gad2‐expressing neurons in the VTA as measured by increased Fos transcript expression. In summary, we find that sazetidine‐A enhances the expression of alcohol aversion, which may underlie the reduction in alcohol consumption induced by sazetidine‐A. Elucidating the identity of non‐α4 nAChRs in alcohol aversion mechanisms will provide a better understanding the complex role of nAChRs in alcohol addiction and potentially reveal novel drug targets to treat AUDs. Sazetidine‐A enhanced the expression of alcohol aversion in the conditioned place aversion test and had no effect on the expression or acquisition of conditioned alcohol reward in the conditioned place preference test in mice. Sazetidine‐A did not require the alpha4 nAChR subunit to reduce binge alcohol consumption, implicating non‐alpha4 containing nAChRs. In mice pre‐treated with sazetidine‐A, alcohol induced Fos transcript in Th‐, but not Gad2‐expressing neurons in the VTA as measured by increased Fos transcript expression.
doi_str_mv 10.1111/adb.12908
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7584768</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2489900047</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4438-f9b70da3172c64e89757dfee0124f29f57140cd029fb4f8b37ef6647b3bd9c2b3</originalsourceid><addsrcrecordid>eNp1kU1uFDEQhS0EIiGw4ALIEhtYdOK_9s8GaUhCQIrEBlYsLNtdnXHU0x7s7kSTVY7AGTkJnkyIAIlaVJVUn55e6SH0kpJDWuvIdf6QMkP0I7RPuTQNlYQ83u5t20hG2z30rJRLQihTLX-K9jjjzLRS7aNvp-PSjQFWME449dgNIS3TgN0V5BLTiP0GT0vAYwxpirVjF2DaDKFCcQScIcB6Shl3eb7Axd3AFLt6-Hn7Y_EcPendUODF_TxAXz-cfjn-2Jx_Pvt0vDhvghBcN73xinSOU8WCFKCNalXXA1S3omembxUVJHSkrl702nMFvZRCee47E5jnB-jdTnc9-xV0ob6S3WDXOa5c3tjkov37MsalvUhXVrVaKKmrwJt7gZy-z1Amu4olwDC4EdJcLONGaC2JVBV9_Q96meY81vcsE9oYQojYUm93VMiplAz9gxlK7DYyWyOzd5FV9tWf7h_I3xlV4GgHXMcBNv9XsouT9zvJX3mQom0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2489900047</pqid></control><display><type>article</type><title>Enhancement of alcohol aversion by the nicotinic acetylcholine receptor drug sazetidine‐A</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Touchette, Jillienne C. ; Moen, Janna K. ; Robinson, Jenna M. ; Lee, Anna M.</creator><creatorcontrib>Touchette, Jillienne C. ; Moen, Janna K. ; Robinson, Jenna M. ; Lee, Anna M.</creatorcontrib><description>The prevalence of alcohol use disorders (AUDs) has steadily increased in the United States over the last 30 years. Alcohol acts on multiple receptor systems including the nicotinic acetylcholine receptors (nAChRs), which are known to mediate alcohol consumption and reward. We previously reported that the preclinical drug sazetidine‐A, a nAChR agonist and desensitizer, reduces alcohol consumption without affecting nicotine consumption in C57BL/6J mice. Here, we found that sazetidine‐A enhances the expression of alcohol aversion without affecting the expression or acquisition of conditioned alcohol reward in C57BL/6J mice. Microinjection of sazetidine‐A into the ventral midbrain targeting the ventral tegmental area (VTA) reduced binge alcohol consumption, implicating this region in mediating the effects of sazetidine‐A. Furthermore, the sazetidine‐A‐induced reduction in alcohol consumption was mediated by non‐α4 containing nAChRs, as sazetidine‐A reduced binge alcohol consumption in both α4 knock‐out and wild‐type mice. Finally, we found that in mice pretreated with sazetidine‐A, alcohol induced Fos transcript in Th‐, but not Gad2‐expressing neurons in the VTA as measured by increased Fos transcript expression. In summary, we find that sazetidine‐A enhances the expression of alcohol aversion, which may underlie the reduction in alcohol consumption induced by sazetidine‐A. Elucidating the identity of non‐α4 nAChRs in alcohol aversion mechanisms will provide a better understanding the complex role of nAChRs in alcohol addiction and potentially reveal novel drug targets to treat AUDs. Sazetidine‐A enhanced the expression of alcohol aversion in the conditioned place aversion test and had no effect on the expression or acquisition of conditioned alcohol reward in the conditioned place preference test in mice. Sazetidine‐A did not require the alpha4 nAChR subunit to reduce binge alcohol consumption, implicating non‐alpha4 containing nAChRs. In mice pre‐treated with sazetidine‐A, alcohol induced Fos transcript in Th‐, but not Gad2‐expressing neurons in the VTA as measured by increased Fos transcript expression.</description><identifier>ISSN: 1355-6215</identifier><identifier>EISSN: 1369-1600</identifier><identifier>DOI: 10.1111/adb.12908</identifier><identifier>PMID: 32329567</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>Acetylcholine receptors (nicotinic) ; Addictions ; Alcohol ; Alcohol Deterrents - pharmacology ; Alcoholism - drug therapy ; Animals ; Aversion ; Azetidines - pharmacology ; Binge Drinking - drug therapy ; Drug addiction ; Female ; Fos ; Male ; Mesencephalon ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Microinjection ; Nicotine ; nicotinic acetylcholine receptor ; Nicotinic Agonists - pharmacology ; Proto-Oncogene Proteins c-fos - drug effects ; Pyridines - pharmacology ; Receptors, Nicotinic ; Reinforcement ; Reward ; Therapeutic targets ; Transcription ; Ventral Tegmental Area - drug effects ; Ventral tegmentum ; VTA</subject><ispartof>Addiction biology, 2021-03, Vol.26 (2), p.e12908-n/a</ispartof><rights>2020 Society for the Study of Addiction</rights><rights>2020 Society for the Study of Addiction.</rights><rights>2021 Society for the Study of Addiction</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4438-f9b70da3172c64e89757dfee0124f29f57140cd029fb4f8b37ef6647b3bd9c2b3</citedby><cites>FETCH-LOGICAL-c4438-f9b70da3172c64e89757dfee0124f29f57140cd029fb4f8b37ef6647b3bd9c2b3</cites><orcidid>0000-0003-4551-0082 ; 0000-0001-6167-5472</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fadb.12908$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fadb.12908$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32329567$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Touchette, Jillienne C.</creatorcontrib><creatorcontrib>Moen, Janna K.</creatorcontrib><creatorcontrib>Robinson, Jenna M.</creatorcontrib><creatorcontrib>Lee, Anna M.</creatorcontrib><title>Enhancement of alcohol aversion by the nicotinic acetylcholine receptor drug sazetidine‐A</title><title>Addiction biology</title><addtitle>Addict Biol</addtitle><description>The prevalence of alcohol use disorders (AUDs) has steadily increased in the United States over the last 30 years. Alcohol acts on multiple receptor systems including the nicotinic acetylcholine receptors (nAChRs), which are known to mediate alcohol consumption and reward. We previously reported that the preclinical drug sazetidine‐A, a nAChR agonist and desensitizer, reduces alcohol consumption without affecting nicotine consumption in C57BL/6J mice. Here, we found that sazetidine‐A enhances the expression of alcohol aversion without affecting the expression or acquisition of conditioned alcohol reward in C57BL/6J mice. Microinjection of sazetidine‐A into the ventral midbrain targeting the ventral tegmental area (VTA) reduced binge alcohol consumption, implicating this region in mediating the effects of sazetidine‐A. Furthermore, the sazetidine‐A‐induced reduction in alcohol consumption was mediated by non‐α4 containing nAChRs, as sazetidine‐A reduced binge alcohol consumption in both α4 knock‐out and wild‐type mice. Finally, we found that in mice pretreated with sazetidine‐A, alcohol induced Fos transcript in Th‐, but not Gad2‐expressing neurons in the VTA as measured by increased Fos transcript expression. In summary, we find that sazetidine‐A enhances the expression of alcohol aversion, which may underlie the reduction in alcohol consumption induced by sazetidine‐A. Elucidating the identity of non‐α4 nAChRs in alcohol aversion mechanisms will provide a better understanding the complex role of nAChRs in alcohol addiction and potentially reveal novel drug targets to treat AUDs. Sazetidine‐A enhanced the expression of alcohol aversion in the conditioned place aversion test and had no effect on the expression or acquisition of conditioned alcohol reward in the conditioned place preference test in mice. Sazetidine‐A did not require the alpha4 nAChR subunit to reduce binge alcohol consumption, implicating non‐alpha4 containing nAChRs. In mice pre‐treated with sazetidine‐A, alcohol induced Fos transcript in Th‐, but not Gad2‐expressing neurons in the VTA as measured by increased Fos transcript expression.</description><subject>Acetylcholine receptors (nicotinic)</subject><subject>Addictions</subject><subject>Alcohol</subject><subject>Alcohol Deterrents - pharmacology</subject><subject>Alcoholism - drug therapy</subject><subject>Animals</subject><subject>Aversion</subject><subject>Azetidines - pharmacology</subject><subject>Binge Drinking - drug therapy</subject><subject>Drug addiction</subject><subject>Female</subject><subject>Fos</subject><subject>Male</subject><subject>Mesencephalon</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Microinjection</subject><subject>Nicotine</subject><subject>nicotinic acetylcholine receptor</subject><subject>Nicotinic Agonists - pharmacology</subject><subject>Proto-Oncogene Proteins c-fos - drug effects</subject><subject>Pyridines - pharmacology</subject><subject>Receptors, Nicotinic</subject><subject>Reinforcement</subject><subject>Reward</subject><subject>Therapeutic targets</subject><subject>Transcription</subject><subject>Ventral Tegmental Area - drug effects</subject><subject>Ventral tegmentum</subject><subject>VTA</subject><issn>1355-6215</issn><issn>1369-1600</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU1uFDEQhS0EIiGw4ALIEhtYdOK_9s8GaUhCQIrEBlYsLNtdnXHU0x7s7kSTVY7AGTkJnkyIAIlaVJVUn55e6SH0kpJDWuvIdf6QMkP0I7RPuTQNlYQ83u5t20hG2z30rJRLQihTLX-K9jjjzLRS7aNvp-PSjQFWME449dgNIS3TgN0V5BLTiP0GT0vAYwxpirVjF2DaDKFCcQScIcB6Shl3eb7Axd3AFLt6-Hn7Y_EcPendUODF_TxAXz-cfjn-2Jx_Pvt0vDhvghBcN73xinSOU8WCFKCNalXXA1S3omembxUVJHSkrl702nMFvZRCee47E5jnB-jdTnc9-xV0ob6S3WDXOa5c3tjkov37MsalvUhXVrVaKKmrwJt7gZy-z1Amu4olwDC4EdJcLONGaC2JVBV9_Q96meY81vcsE9oYQojYUm93VMiplAz9gxlK7DYyWyOzd5FV9tWf7h_I3xlV4GgHXMcBNv9XsouT9zvJX3mQom0</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Touchette, Jillienne C.</creator><creator>Moen, Janna K.</creator><creator>Robinson, Jenna M.</creator><creator>Lee, Anna M.</creator><general>John Wiley &amp; Sons, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7T5</scope><scope>7TM</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4551-0082</orcidid><orcidid>https://orcid.org/0000-0001-6167-5472</orcidid></search><sort><creationdate>202103</creationdate><title>Enhancement of alcohol aversion by the nicotinic acetylcholine receptor drug sazetidine‐A</title><author>Touchette, Jillienne C. ; Moen, Janna K. ; Robinson, Jenna M. ; Lee, Anna M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4438-f9b70da3172c64e89757dfee0124f29f57140cd029fb4f8b37ef6647b3bd9c2b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acetylcholine receptors (nicotinic)</topic><topic>Addictions</topic><topic>Alcohol</topic><topic>Alcohol Deterrents - pharmacology</topic><topic>Alcoholism - drug therapy</topic><topic>Animals</topic><topic>Aversion</topic><topic>Azetidines - pharmacology</topic><topic>Binge Drinking - drug therapy</topic><topic>Drug addiction</topic><topic>Female</topic><topic>Fos</topic><topic>Male</topic><topic>Mesencephalon</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Microinjection</topic><topic>Nicotine</topic><topic>nicotinic acetylcholine receptor</topic><topic>Nicotinic Agonists - pharmacology</topic><topic>Proto-Oncogene Proteins c-fos - drug effects</topic><topic>Pyridines - pharmacology</topic><topic>Receptors, Nicotinic</topic><topic>Reinforcement</topic><topic>Reward</topic><topic>Therapeutic targets</topic><topic>Transcription</topic><topic>Ventral Tegmental Area - drug effects</topic><topic>Ventral tegmentum</topic><topic>VTA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Touchette, Jillienne C.</creatorcontrib><creatorcontrib>Moen, Janna K.</creatorcontrib><creatorcontrib>Robinson, Jenna M.</creatorcontrib><creatorcontrib>Lee, Anna M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Addiction biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Touchette, Jillienne C.</au><au>Moen, Janna K.</au><au>Robinson, Jenna M.</au><au>Lee, Anna M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhancement of alcohol aversion by the nicotinic acetylcholine receptor drug sazetidine‐A</atitle><jtitle>Addiction biology</jtitle><addtitle>Addict Biol</addtitle><date>2021-03</date><risdate>2021</risdate><volume>26</volume><issue>2</issue><spage>e12908</spage><epage>n/a</epage><pages>e12908-n/a</pages><issn>1355-6215</issn><eissn>1369-1600</eissn><abstract>The prevalence of alcohol use disorders (AUDs) has steadily increased in the United States over the last 30 years. Alcohol acts on multiple receptor systems including the nicotinic acetylcholine receptors (nAChRs), which are known to mediate alcohol consumption and reward. We previously reported that the preclinical drug sazetidine‐A, a nAChR agonist and desensitizer, reduces alcohol consumption without affecting nicotine consumption in C57BL/6J mice. Here, we found that sazetidine‐A enhances the expression of alcohol aversion without affecting the expression or acquisition of conditioned alcohol reward in C57BL/6J mice. Microinjection of sazetidine‐A into the ventral midbrain targeting the ventral tegmental area (VTA) reduced binge alcohol consumption, implicating this region in mediating the effects of sazetidine‐A. Furthermore, the sazetidine‐A‐induced reduction in alcohol consumption was mediated by non‐α4 containing nAChRs, as sazetidine‐A reduced binge alcohol consumption in both α4 knock‐out and wild‐type mice. Finally, we found that in mice pretreated with sazetidine‐A, alcohol induced Fos transcript in Th‐, but not Gad2‐expressing neurons in the VTA as measured by increased Fos transcript expression. In summary, we find that sazetidine‐A enhances the expression of alcohol aversion, which may underlie the reduction in alcohol consumption induced by sazetidine‐A. Elucidating the identity of non‐α4 nAChRs in alcohol aversion mechanisms will provide a better understanding the complex role of nAChRs in alcohol addiction and potentially reveal novel drug targets to treat AUDs. Sazetidine‐A enhanced the expression of alcohol aversion in the conditioned place aversion test and had no effect on the expression or acquisition of conditioned alcohol reward in the conditioned place preference test in mice. Sazetidine‐A did not require the alpha4 nAChR subunit to reduce binge alcohol consumption, implicating non‐alpha4 containing nAChRs. In mice pre‐treated with sazetidine‐A, alcohol induced Fos transcript in Th‐, but not Gad2‐expressing neurons in the VTA as measured by increased Fos transcript expression.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>32329567</pmid><doi>10.1111/adb.12908</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-4551-0082</orcidid><orcidid>https://orcid.org/0000-0001-6167-5472</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1355-6215
ispartof Addiction biology, 2021-03, Vol.26 (2), p.e12908-n/a
issn 1355-6215
1369-1600
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7584768
source MEDLINE; Access via Wiley Online Library
subjects Acetylcholine receptors (nicotinic)
Addictions
Alcohol
Alcohol Deterrents - pharmacology
Alcoholism - drug therapy
Animals
Aversion
Azetidines - pharmacology
Binge Drinking - drug therapy
Drug addiction
Female
Fos
Male
Mesencephalon
Mice
Mice, Inbred C57BL
Mice, Knockout
Microinjection
Nicotine
nicotinic acetylcholine receptor
Nicotinic Agonists - pharmacology
Proto-Oncogene Proteins c-fos - drug effects
Pyridines - pharmacology
Receptors, Nicotinic
Reinforcement
Reward
Therapeutic targets
Transcription
Ventral Tegmental Area - drug effects
Ventral tegmentum
VTA
title Enhancement of alcohol aversion by the nicotinic acetylcholine receptor drug sazetidine‐A
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T14%3A09%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhancement%20of%20alcohol%20aversion%20by%20the%20nicotinic%20acetylcholine%20receptor%20drug%20sazetidine%E2%80%90A&rft.jtitle=Addiction%20biology&rft.au=Touchette,%20Jillienne%20C.&rft.date=2021-03&rft.volume=26&rft.issue=2&rft.spage=e12908&rft.epage=n/a&rft.pages=e12908-n/a&rft.issn=1355-6215&rft.eissn=1369-1600&rft_id=info:doi/10.1111/adb.12908&rft_dat=%3Cproquest_pubme%3E2489900047%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2489900047&rft_id=info:pmid/32329567&rfr_iscdi=true